Package Leaflet: Information for the Patient
Fesoterodina Liconsa 4 mg prolonged-release tablets EFG
Fesoterodina Liconsa 8 mg prolonged-release tablets EFG
fesoterodine, fumarate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
This medication contains the active substance fesoterodine fumarate and is a treatment called antimuscarinics, which reduce the activity of the overactive bladder and is used in adults to treat symptoms.
Fesoterodina treats symptoms of an overactive bladder, such as:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Fesoterodina Liconsa.
Fesoterodina may not always be suitable for you. Talk to your doctor before taking fesoterodine in any of the following cases:
Heart problems: Inform your doctor if you have any of the following conditions:
Children and adolescents
Do not give this medication to children and adolescents under 18 years of age because it has not been established whether it can work and whether it would be safe for them.
Other medications and Fesoterodina Liconsa
Tell your doctor or pharmacist if you are taking or have recently taken or may need to take any other medication. Your doctor will tell you if you can use fesoterodine with other medications.
Please inform your doctor if you are taking medications from the list below. Taking these medications at the same time as fesoterodine may cause side effects such as dry mouth, constipation, difficulty emptying the bladder, or more frequent or severe drowsiness.
Please indicate to your doctor if you are taking any of the following medications:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
You should not take fesoterodine if you are pregnant, as the effects of fesoterodine on pregnancy and the newborn are unknown.
It is unknown whether fesoterodine is excreted in breast milk; therefore, do not breastfeed during treatment with this medication.
Driving and using machines
Fesoterodina may cause blurred vision, dizziness, and drowsiness. If you experience any of these effects, do not drive or operate tools or machines.
Fesoterodina Liconsa contains lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Fesoterodina Liconsa contains fructose
This medication contains 72 mg of fructose in each tablet.
Follow your doctor's instructions for taking this medication exactly. If in doubt, consult your doctor or pharmacist again.
The recommended initial dose is one 4 mg fesoterodine tablet per day. Depending on how you respond to the medication, your doctor may prescribe a higher dose; one 8 mg fesoterodine tablet per day.
Swallow the tablet whole with a glass of water. Do not chew the tablet. This medication can be taken with or without food.
To help you remember to take your medication, it may be easier to take it at the same time every day.
If you take more Fesoterodina Liconsa than you should
If you have taken more tablets than you should or if someone else has taken your tablets by accident, contact your doctor or hospital immediately. Show them the package of tablets.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Fesoterodina Liconsa
If you have forgotten to take a tablet, take it as soon as you remember, but do not take more than one tablet in a day. Do not take a double dose to make up for forgotten doses.
If you stop taking Fesoterodina Liconsa
Do not stop taking fesoterodine without talking to your doctor first, as the symptoms of overactive bladder may return or worsen when you stop taking this medication.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some side effects can be serious
Other side effects
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Medicines and Healthcare Products Agency (AEMPS) through the website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the packaging and blister, after “EXP”. The expiration date is the last day of the month indicated.
Do not store above 25°C.
Keep in the original packaging to protect from moisture.
Medicines should not be disposed of via wastewater or household waste. Return the packaging and any unused medication to the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Fesoterodina Liconsa 4 mg prolonged-release tablets EFG: Each prolonged-release tablet contains 4 mg of fesoterodine fumarate, equivalent to 3.1 mg of fesoterodine.
Fesoterodina Liconsa 8 mg prolonged-release tablets EFG: Each prolonged-release tablet contains 8 mg of fesoterodine fumarate, equivalent to 6.2 mg of fesoterodine.
Core of the tablet: fructose, lactose monohydrate, microcrystalline cellulose, hypromellose, dibehenate of glycerol, talc.
Coating of the tablet: poly(vinyl alcohol), titanium dioxide (E171), macrogol, talc, and carmine indigo (E132).
Appearance of the product and contents of the pack
Fesoterodina Liconsa 4 mg: film-coated tablets, elliptical, biconvex, blue, approximately 6 mm in diameter, engraved with “F4” on one side and smooth on the other.
Fesoterodina Liconsa 8 mg: film-coated tablets, elliptical, biconvex, dark blue, approximately 6 mm in diameter, engraved with “F8” on one side and smooth on the other.
Fesoterodina Liconsa is available in blister packs of 14, 28, 30, 56, 84, 98, and 100 prolonged-release tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder
Laboratorios Liconsa S.A.
C/ Dulcinea S/N, 28805 Alcalá de Henares,
Madrid – Spain
Manufacturer
Laboratorios Liconsa, S.A.
Avda. Miralcampo, 7
Polígono Industrial Miralcampo,
19200 Azuqueca de Henares, Guadalajara
Spain
or
Laboratorios Normon, S.A.
Ronda Valdecarrizo 6
28760 Tres Cantos, Madrid
Spain
Date of last revision of this leaflet:06/2024
Detailed information on this medication is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es.